Radiosensitivity of Angiogenic and Mitogenic Factors in Human Amniotic Membrane


Custer C. Deocaris, Chester C. Deocaris, Sonia D. Jacinto and Zenaida M. De Guzman

National Institute of Advanced Industrial Science and Technology
1-1-1 Higashi, Tsukuba Science City 305-8562, Japan

corresponding author: This email address is being protected from spambots. You need JavaScript enabled to view it.



Amniotic membrane as a temporary biological dressing remains as a beneficial and cost-effective means of treating burns in developing countries. This medical application is attributed mainly to placental structural and biochemical features that are important for maintaining proper embryonic development. Since fresh amnions are nevertheless for straightforward clinical use and for preservation, radiation-sterilization is been performed to improve the safety of this placental material. However, like any other sterilization method, gamma-radiation may induce physical and chemical changes that may influence the biological property of the material. Thus, the aim of this study is to compare the effects of various levels of radiation-sterilization protocols for human amnions on angiogenic (neovascularization) and epithelial-mitogenic activities, both of which are physiological processes fundamental to wound healing. Water-soluble extract of non-irradiated amnions demonstrates a strong stimulatory effect on both cell proliferation and angiogenesis. No change in biological activity is seen in amnions irradiated at 25 kGy, the sterilization dose used by the Philippine Nuclear Research Institute (PNRI) for the production of radiation-sterilized human amniotic membranes (RSHAM). However, it appears that amniotic angiogenic factors are more radiosensitive than its mitogenic components, evident from the depressed vascularization of the chorioallantoic membrane (CAM) exposed to 35 kGy-irradiated amnions. The dose of 35 kGy is at present the medical sterilization dose used at the Central Tissue Bank in Warsaw (Poland) for the preparation of their amnion allografts.



The use of human amniotic membranes for would coverage was first published 1913 (Sabella 1913). Until now, outcomes of clinical trials on its application in supportive care for would and burn cases, dermabrasions and skin ulcers, plastic surgery, laryngology, and for spinal ocular surgical procedures are still being. . . . . 





AGCAOILI NR, SINGSON C, DE GUZMAN Z, LANUZA I, YLESCUPIDES F, VILLANUEVA J, VILLARUEL C, MONTALBAN A, RAMIREZ A, DISCUSION A. 1988 The preparation of radiation-sterilized freeze-dried amnion. In: Radiation Sterilization Practices for Tissue Grafts in Clinical Use for Asia and the Pacific Region. UNDP/IAEA/RCA.

ALTMAN KI, GERBER GB, OKADA S. 1970 Radiation Biochemistry. Academic Press: New York.

[AAMI] Association for the Advancement of Medical Instrumentation. 1991. Guidelines For Gamma-Radiation Sterilization. ANS/AAMI ST32.

CAMPBELL DG, LI P, STEPHENSON AJ, OAKSHOT RD. 1994. Sterilization of HIV by gamma irradiation. Int. Ortho. (SICOT) 18: 172-176.

DEOCARIS CC, ARANILLA A, TANGONAN MA, ALIGANGA A, CHUA YM, VALERA N, DE GUZMAN Z, DEOCARIS CC. 2004. Some physico-chemical and mechanical analysis of irradiated human amniotic membranes. Philipp. J. Sci. (in press)

DEOCARIS CC, PEREZ MST, GUTTIEREZ KV. 2003. Human amnion extract as radioprotector. Philipp. Nuclear J. (in press)

DINO BR, EUFEMIO GG, DE VILLA MS. 1966. Human amnion, the establishment of an amnion bank and its practical applications in surgery. J. Phil. Med. Assoc. 42: 357-366.

DJEFALL A, MAHLOUS A, NACER KA, LARBI DB. 1998. Freeze-dried, radiation-sterilized human amniotic membrane in the treatment of burn wound: the Algerian experience. Proceedings of the 7th International Conference of Tissue Banking APASTB. 68p.

DUA HS, AZUARA-BLANCO A. 1999. Amniotic membrane transplantation. Br. J. Ophthalmol. 83(6): 748-52.

DUDLEY DJ, TRAUTMAN MS, MITCHELL MD. 1993. Inflammatory mediators regulate IL-8 production by cultured gestational tissues: evidence for a cytokine network at the chorio-decidual interface. J. Clin. Endoc. Metab. 76: 404-410.

FALANGA V. 1993. Chronic wounds: pathophysiologic and experimental considerations. J. Invest. Dermatol. 100: 721-725. 

GAMERO EC, PEREZ NC. 1998. Elaboration of amniotic membrane dressings by air and radiation: the Peruvian experience. Proceedings of the 7th International Conference of Tissue Banking APASTB. 72p.

GOSPODAROWICZ D, NEUFELD G, SCHWEIGERER R. 1986. Fibroblast growth factor. Mol. Cell Endocrin. 46: 187-206.

HAI, TB, KIET TD, LAP VC, THANG DX, HUNG DQ, VU VT, ANG NH, HIEN NQ, HAI L, TRUNG DQ. 1992. Biological dressings from lyophilized and irradiated amniotic membranes. In the Proceedings of the 4th Meeting of APASTB, Manila, Philippines from 6-8 August 1992.

HANSBROUGH JF. 1987. Biological dressings. In: The Art and Science of Burn Care., Boswick J (ed.). Rockville, Maryland: Aspen Publishing Inc. p. 57-63.

HANSBROUGH JF. 1992. Wound Coverage: With Biological Dressings and Cultured Skin Substitutes. Austin, R.G. Landers Company, USA.

HU DE, HORI Y, FAN TPD. 1993. IL-8 stimulare angiogenesis in rats. Inflammation. 17: 165-143.

[ISO] International Standards Organization. 1993. Sterilization of health care products—Validation and routine control: Gamma and electron bean radiation sterilization. Draft International Standard (ISO/DIS 11137).

[IAEA] International Atomic Energy Agency. 1990. Guidelines for Industrial Radiation Sterilization of Disposable Medical Product. TECDOC-539.

JACKSON D, VOLPERT OV, BOUCK N, LINZER DIH. 1994. Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein. Science 266: 1581-84.

MICHEL G, KEMENY I, PETER RU, BETZ A, RIED C, ARENBERGER P, RUZICKA T. 1992. IL-8 receptormediated chemotaxis of normal human epidermal cells. FEBS Lett. 305: 241-243.

MITCHELL MD, DUDLEY DJ, EDWIN SS, LUNDIN-SCHILLER S. 1991. IL-8 stimulates prostaglandin production by human amnion and decidual cells. Eur. J. Pharmacol. 192: 189-191.

NORRBY K. 1997. Angiogenesis: new aspects relating to its initiation and control. APMIS 105(6): 417-37.

PETER G, BATES S, PARRY D. 1996. D-cyclins, their kinases and their inhibitors. In Apoptosis and Cell Cycle Control in Cancer. SB Thomas (ed.). BIOS Scietific Publishers, Ltd. UK. p. 37-48.

[PNRI-DOST] Philippine Nuclear Research Institute - Department of Science and Technology. 2001. Annual Report. 40p.

PHILIPS GO. 1994. Radiation technology in surgery and the pharmaceutical industry: An overview of applications. IAEA Bull. 36(1): 19-23.

RAMAKRISHNAN KM, JAYARAMAN V. 1997. Management of partial-thickness burn wounds by amniotic membrane: a cost-effective treatment in developing countries. Burns. 23 Suppl 1: S33-6.

RAMSEY EM. 1982. The Placenta. Prager, New York.

REUSCH MK, STUDTMANN M, SCHRODER JM, STICHERLING M, CHRISTOPHERS E. 1990. NAP/IL-8 is a potent mitogen for human keratinocytes in vitro. J. Invest. Dermatol. 95A: 485.

REYNOLDS LP, REDMER DA. 2001. Angiogenesis in the placenta. Biol. Reprod. 64(4): 1033-40.

SABELLA N. 1913. Use of fetal membranes in skin grafting. Med. Rec. 83: 478.

SCOTT-CONNOR CE, MEYDRECH E, WHEELER WE, COIL JA. 1988. Quantitation of rate of wound closure and the prediction of death following major burns. Burns 14: 373-378.

SHARMA SC, BAGREE MM, BHAT AL, BANGA BB, SINGH MP. 1985. Amniotic membrane is an effective burn dressing material. Jpn. J. Surg. 15(2): 140-3.

TALLENTIRE A. 1986. Good manufacturing practice in relation to Sterility Assurance Level – Microbiological aspects. Executive Management Seminar on Radiation Sterilization of Medical Products, Kuala Lumpur, Malaysia.

TRAUTMAN MS, DUDLEY DJ, EDWIN SS, COLLMAR D, MITCHELL MD. 1992. Amnion cell biosynthesis of IL-8: regulation by inflammatory cytokines. J. Cell Physiol. 153: 38-43.

TYSZKIEWICZ JT, UHRYNOWSKA-TYSZKIEWICZ IA, KAMINSKI A, DZIEDZIC-GOCLAWSKA A. 1999. Amnion allografts prepared in the Central Tissue Bank in Warsaw. Ann. Transplant. 4(3-4): 85-90.

ZEIGLER TR, PIERCE GF, HERNDON DN. 1997. Growth Factors and Wound Healing: Basic Science and Potential Clinical Applications. Springer-Verlag: New York.

ZHU YP, WORD RA, JOHNSTON JM. 1992. The presence of PAF binding sites in human myometrium and its role in uterine contraction . Am. J. Obstet. Gynecol. 166: 1222.